The deep-sea constitutes a true unexplored frontier and a potential source of innovative drug scaffolds. Here, we present the genome sequence of two novel marine actinobacterial strains, MA3_2.13 and S07_1.15, isolated from deep-sea samples (sediments and sponge) and collected at Madeira archipelago (NE Atlantic Ocean; Portugal). The de novo assembly of both genomes was achieved using a hybrid strategy that combines short-reads (Illumina) and long-reads (PacBio) sequencing data. Phylogenetic analyses showed that strain MA3_2.13 is a new species of the Streptomyces genus, whereas strain S07_1.15 is closely related to the type strain of Streptomyces xinghaiensis. In silico analysis revealed that the total length of predicted biosynthetic gene...
Ian E, Malko DB, Sekurova ON, et al. Genomics of Sponge-Associated Streptomyces spp. Closely Related...
A total of 74 actinomycete isolates were cultivated from two marine sponges, Geodia barretti and Pha...
Natural products and their derivatives account for the majority of approved drugs. New antibiotics a...
The deep-sea constitutes a true unexplored frontier and a potential source of innovative drug scaffo...
FCT/MEC (PTDC/QUIQUI/119116/2010; IF/00700/2014; UID/QUI/50006/2013; UID/Multi/04378/2013) ERDF (POC...
Abstract Global antimicrobial resistance is a health crisis that can change the face of modern medi...
The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. ...
Marine actinobacteria are drawing more and more attention as a promising source of new natural produ...
Metabolomic analysis has shown the chemical richness of the sponge-associated actinomycetes. Strepto...
Guerrero-Garzón JF, Zehl M, Schneider O, et al. Streptomyces spp. From the Marine Sponge Antho dicho...
AbstractMarine streptomycetes are rich sources of natural products with novel structures and interes...
The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. ...
The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. ...
In recent years, marine genomics has become a growning rapidly field, helped by the large amount of ...
Many marine sponges harbor dense communities of microbes that aid in the chemical defense of these n...
Ian E, Malko DB, Sekurova ON, et al. Genomics of Sponge-Associated Streptomyces spp. Closely Related...
A total of 74 actinomycete isolates were cultivated from two marine sponges, Geodia barretti and Pha...
Natural products and their derivatives account for the majority of approved drugs. New antibiotics a...
The deep-sea constitutes a true unexplored frontier and a potential source of innovative drug scaffo...
FCT/MEC (PTDC/QUIQUI/119116/2010; IF/00700/2014; UID/QUI/50006/2013; UID/Multi/04378/2013) ERDF (POC...
Abstract Global antimicrobial resistance is a health crisis that can change the face of modern medi...
The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. ...
Marine actinobacteria are drawing more and more attention as a promising source of new natural produ...
Metabolomic analysis has shown the chemical richness of the sponge-associated actinomycetes. Strepto...
Guerrero-Garzón JF, Zehl M, Schneider O, et al. Streptomyces spp. From the Marine Sponge Antho dicho...
AbstractMarine streptomycetes are rich sources of natural products with novel structures and interes...
The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. ...
The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. ...
In recent years, marine genomics has become a growning rapidly field, helped by the large amount of ...
Many marine sponges harbor dense communities of microbes that aid in the chemical defense of these n...
Ian E, Malko DB, Sekurova ON, et al. Genomics of Sponge-Associated Streptomyces spp. Closely Related...
A total of 74 actinomycete isolates were cultivated from two marine sponges, Geodia barretti and Pha...
Natural products and their derivatives account for the majority of approved drugs. New antibiotics a...